The headline finding from Denmark feels sudden. The science behind it is not. Researchers have spent nearly a decade assembling the case that tattoo ink does more than color the skin, and the latest twin study sits at the end of a long evidentiary chain that began with a beam of X-rays.
A discovery in Grenoble
In 2017, scientists at the European Synchrotron Radiation Facility in France did something no one had managed before. They tracked tattoo pigment inside human tissue, atom by atom.
Working with researchers from Germany’s German Federal Institute for Risk Assessment, the team used X-ray fluorescence to examine the skin and lymph nodes of four donated bodies. They confirmed that ink particles travel from the injection site and lodge in the lymph nodes, where the body filters waste and mounts immune defenses.
The particles arrived in two sizes. Larger pigment fragments stayed in the skin. Smaller fragments, some measuring less than 100 nanometers across, slipped into the lymphatic system and remained there.
That study answered one question and raised a harder one. Scientists now knew where the ink went. They did not know what it did once it arrived.
From mechanism to population
Proving that pigment reaches the lymph nodes is one thing. Proving that it raises cancer risk across a population takes far larger numbers and far more time.
In 2024, researchers at Lund University in Sweden published one of the first large attempts. They compared lymphoma cases with population controls and found a modest increase in risk among tattooed people, especially for diffuse large B-cell lymphoma.
That same year, a team at the University of Utah examined the association between tattooing and blood cancers in a study of 820 cases and more than 8,000 controls. The work added a chemical dimension to the conversation. Commercial inks can carry heavy metals and compounds that the International Agency for Research on Cancer classifies as carcinogenic or probably carcinogenic.
Each study carried its own limits and uncertainties. Together, they pushed the question from the laboratory bench toward public health.
The twin advantage
The newest entry came from the University of Southern Denmark and the University of Helsinki, published in January 2025. Its central tool was the Danish Twin Tattoo Cohort, a survey of Danish twins assembled in 2021.
Twins give researchers a way to separate the effects of tattoos from those of genes and shared upbringing. When one twin has a tattoo, and the other does not, the comparison strips away much of the noise that muddies other studies.
The team analyzed a cohort of 2,367 twins and a separate case-control group of 316 twins drawn from that survey. They linked each person to the Danish Cancer Registry to track diagnoses over time.
Tattooed individuals showed higher rates of skin cancer and lymphoma than those without ink.
Size and time matter
The size of the tattoo changed the picture. People with tattoos larger than the palm of a hand carried a hazard of lymphoma about 2.7 times that of people without tattoos. The figure for skin cancer followed a similar pattern.
The researchers read that gradient as a clue about the mechanism. A larger tattoo, present for longer, deposits more pigment in the lymph nodes.
“This suggests that the bigger the tattoo and the longer it has been there, the more ink accumulates in the lymph nodes,” said Signe Bedsted Clemmensen, an assistant professor of biostatistics at the University of Southern Denmark.
What the numbers cannot say yet
Every team in this lineage has stressed the same caution. These studies show association, not proof of cause. Cancer develops slowly, often over decades, making it hard to measure the true long-term effect in people who began getting tattooed only recently.
The stakes are not small. About one-third of U.S. adults now have at least one tattoo, according to the Pew Research Center, and the share climbs above 40 percent among adults under 30. A risk factor that affects so many people deserves a clear answer.
The work now turns to the cellular level, where researchers hope to learn what pigment actually does to immune tissue over a lifetime. The synchrotron showed where the ink rests. The next decade may finally show what it costs.
The full study was published in the journal BMC Public Health.
—-
Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.
Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
——
